# Mental and Behavioral Health Disparities Among Pain-Reliever Misusers: A Cross-Sectional Analysis by Race and Ethnicity

**Authors:** James P. D’Etienne, Sam Abduganiev, Ryan Warrior, Hao Wang

PMC · DOI: 10.3390/healthcare13212674 · Healthcare · 2025-10-23

## TL;DR

This study finds that pain-reliever misuse is linked to mental health issues and varies by race and ethnicity, with Hispanic individuals having the highest rates.

## Contribution

The study identifies racial and ethnic disparities in pain-reliever misuse and its associations with mental health outcomes using U.S. national survey data.

## Key findings

- Hispanic individuals had the highest rate of pain-reliever misuse (3.61%) compared to other racial and ethnic groups.
- Misusers reported higher rates of psychological distress, suicidal thoughts, and daily functioning difficulties than non-misusers.
- Being female, employed, and having higher education were associated with lower odds of pain-reliever misuse.

## Abstract

Objectives: The misuse of pain relievers has been linked to mental and behavioral disorders. This study aims to determine the associations between pain-reliever misuse, severe psychological distress (SPD), suicidal ideation, and difficulties in performing daily activities. Additionally, it seeks to identify the socio-demographic factors associated with pain-reliever misuse across different racial and ethnic groups. Methods: This cross-sectional study utilizes data from the 2022 United States National Survey on Drug Use and Health (NSDUH). Participants were categorized into four groups: non-Hispanic White (NHW), non-Hispanic Black (NHB), Hispanic/Latino (Hispanic), and Other (American Indian, Alaska Native, Asian, Native Hawaiian or other Pacific Islanders, and two or more races) groups. Comparisons were made between individuals regarding pain-reliever misuse, socio-demographic characteristics, SPD, suicidal thoughts, and World Health Organization Disability Assessment Schedule (WHODAS) scores, using Rao–Scott Chi-square tests. Stepwise multivariable logistic regression analyses were conducted to identify socio-demographic factors associated with pain-reliever misuse. Results: The study included 45,451 participants, with 27,551 (62.00 wt%) identified as NHW, 5186 (11.98 wt%) as NHB, 7795 (17.15 wt%) as Hispanic, and 4919 (8.87 wt%) as other racial and ethnic groups. The rate of pain-reliever misuse was 2.90% among NHWs, 3.40% among NHBs, 3.61% among Hispanics, and 2.05% among individuals of other races and ethnicities (p = 0.043). Among those who misused pain relievers, a significantly higher proportion experienced SPD (36.00% vs. 14.05%), suicidal thoughts (15.51% vs. 4.91%), and difficulties in performing daily activities (73.77% vs. 52.84%) compared to those who did not misuse pain relievers (p < 0.001). Socio-demographic factors associated with a lower risk of misuse included being female (AOR = 0.80, 95% CI 0.67–0.95, p = 0.013), being employed (AOR = 0.66, 95% CI 0.48–0.90, p = 0.010), and having a college or higher education (AOR = 0.54, 95% CI 0.37–0.79, p = 0.002). Conclusions: The prevalence of pain-reliever misuse varies across racial and ethnic groups, with Hispanic individuals demonstrating the highest rates of misuse. Pain-reliever misuse is strongly associated with SPD, suicidal thoughts, and impaired daily functioning. Socio-demographic factors are crucial in predicting the likelihood of pain-reliever misuse. These findings highlight the importance of culturally tailored prevention strategies and public health policies aimed at mitigating misuse, especially among vulnerable populations.

## Full-text entities

- **Diseases:** psychological distress (MESH:D012128), impaired daily functioning (MESH:D020773), Mental and Behavioral Health Disparities (OMIM:603663), Pain (MESH:D010146), SPD (MESH:D045169), mental and behavioral disorders (MESH:D001523)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12607855/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12607855/full.md

## References

49 references — full list in the complete paper: https://tomesphere.com/paper/PMC12607855/full.md

---
Source: https://tomesphere.com/paper/PMC12607855